APHEXDA
Active substance: motixafortide
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · MOTIXAFORTIDE ACETATE 62 mg/1.7mL
United StatesActive
Marketing holder: Gamida Cell Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- MOTIXAFORTIDE ACETATE · 62 mg/1.7mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-3716-7f63-90e2-31a8973a2328,01a12095-1d26-74c8-bb40-4330ea799c0f;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 73441-062
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 73441-062 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 73441-062 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 73441-062 · Verified 2026-10-09 · open in source